Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
Authors:
- Carlos A FedrigoCFCarlos A Fedrigo
- Ivana GrivicichIGIvana Grivicich
- Daniel P SchunemannDSDaniel P Schunemann
- Ivan M ChemaleICIvan M Chemale
- Daiane dos SantosDSDaiane dos Santos
- Thais JacovasTJThais Jacovas
- Patryck S BoschettiPBPatryck S Boschetti
- Geraldo P JotzGJGeraldo P Jotz
- Aroldo Braga FilhoAFAroldo Braga Filho
- Adriana B da RochaARAdriana B da Rocha
Open Access
- 11 November 2011
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 156
Abstract
Background: Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished susceptibility of the irradiated cells to undergo cell death. Thus, cells have evolved an elegant system in response to ionizing radiation induced DNA damage, where p53, Hsp70 and/or EGFr may play an important role in the process. In the present study, we investigated whether the content of p53, Hsp70 and EGFr are associated to glioblastoma (GBM) cell radioresistance. Methods: Spheroids from U-87MG and MO59J cell lines as well as spheroids derived from primary culture of tumor tissue of one GBM patient (UGBM1) were irradiated (5, 10 and 20 Gy), their relative radioresistance were established and the p53, Hsp70 and EGFr contents were immunohistochemically determined. Moreover, we investigated whether EGFr-phospho-Akt and EGFr-MEK-ERK pathways can induce GBM radioresistance using inhibitors of activation of ERK (PD098059) and Akt (wortmannin). Results: At 5 Gy irradiation UGBM1 and U-87MG spheroids showed growth inhibition whereas the MO59J spheroid was relatively radioresistant. Overall, no significant changes in p53 and Hsp70 expression were found following 5 Gy irradiation treatment in all spheroids studied. The only difference observed in Hsp70 content was the periphery distribution in MO59J spheroids. However, 5 Gy treatment induced a significant increase on the EGFr levels in MO59J spheroids. Furthermore, treatment with inhibitors of activation of ERK (PD098059) and Akt (wortmannin) leads to radiosensitization of MO59J spheroids. Conclusions: These results indicate that the PI3K-Akt and MEK-ERK pathways triggered by EGFr confer GBM radioresistance.Keywords
This publication has 50 references indexed in Scilit:
- Novel Perspectives on p53 Function in Neural Stem Cells and Brain TumorsJournal of Oncology, 2010
- Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorGenes & Development, 2010
- Heat shock protein 70‐binding protein 1 is highly expressed in high‐grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfacesCancer Science, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodiesBritish Journal of Cancer, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor statusBritish Journal of Cancer, 2008
- Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell InteractionsCell Cycle, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐lnositol‐3′‐Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in GlioblastomasBrain Pathology, 2003